AVAC and Treatment Action Group (TAG) welcome today’s announcement that preliminary data from the efficacy trial of Moderna’s mRNA COVID-19 vaccine indicate high-level of protection against COVID-19.
Treatment Action Group (TAG) congratulates President-elect Joe Biden and Vice President-elect Kamala Harris on their ascension to the highest offices of the United States. Their victory in both the popular and electoral vote is historic.
The National Viral Hepatitis Roundtable (NVHR), the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI), and the Treatment Action Group (TAG) today applauded New York State (NYS) Medicaid for removing the requirement that new patients receive prior authorization approval for hepatitis C treatment.
As the COVID-19 pandemic continues to radically shift the global health landscape and alter government/donor commitments, TAG has released this timely brief to explore the impact of COVID-19 on TB research and development (R&D), and how tools, concepts, capacity, and…
On August 12, 2020, former Vice President Joe Biden finally announced his running mate, California Senator Kamala Harris. The ACT NOW: END AIDS Coalition (ANEA) has been seeking information about the Biden team’s plans to end the HIV epidemic since 2019.
Treatment Action Group, the New York City-based research, policy, and advocacy organization, deplores the August 4, 2020 departure of New York’s Department of Health Commissioner, Dr. Oxiris Barbot, MD.
TAG is one of the organizations who supports confidentiality in contact tracing and is applauding the passage of this legislation. As TAG's State and Local Policy Director Annette Gaudino says in this statement, “There can be no effective contact tracing without trust.”
Treatment Action Group (TAG) honors the titanic historic legacy and mourns the recent death of the Honorable John Lewis, U.S. Representative from the 5th Congressional district in Georgia and legendary civil rights leader.
Treatment Action Group (TAG) joins partners, activists, and communities around the U.S. and the world in decrying violence against Black people and those who stand in solidarity with them.
Treatment Action Group (TAG) and the PrEP4All Collaboration welcome results from randomized controlled trials of therapies for COVID-19, but are seriously concerned about claims that data from a National Institutes of Allergy and Infectious Diseases (NIAID) study of the Gilead drug remdesivir...